{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:31:12Z","timestamp":1775575872565,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.retram.2025.103550","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:48:08Z","timestamp":1762645688000},"page":"103550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimerism in blood after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: Results from a cohort study"],"prefix":"10.1016","volume":"74","author":[{"given":"Farah","family":"Khemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs R.","family":"Briant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claire","family":"Gac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Mear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyacinthe","family":"Johnson-Ansah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautier","family":"Petit-Bultez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Parienti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumedaly","family":"Reman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwann","family":"Quelvennec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Chantepie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.retram.2025.103550_bib0001","first-page":"1126\u201133","article-title":"Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes","volume":"56","author":"Yanada","year":"2021","journal-title":"Bone Marrow Transplant. mai"},{"issue":"12","key":"10.1016\/j.retram.2025.103550_bib0002","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103550_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100673","article-title":"Is microchimerism a sign of imminent disease recurrence after allogeneic hematopoietic stem cell transplantation? A systematic review of the literature","volume":"44","author":"Haugaard","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.retram.2025.103550_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.841608","article-title":"Analysis of subset chimerism for MRD-detection and pre-emptive treatment in AML","volume":"12","author":"Georgi","year":"2022","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.retram.2025.103550_bib0005","first-page":"4618\u201125","article-title":"Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction","volume":"99","author":"Alizadeh","year":"2002","journal-title":"Blood. 15 juin"},{"issue":"1","key":"10.1016\/j.retram.2025.103550_bib0006","first-page":"4\u201110","article-title":"International, multicenter Standardization of Acute graft-versus-Host disease clinical Data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation. janv"},{"issue":"3","key":"10.1016\/j.retram.2025.103550_bib0007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in chronic graft-versus-Host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"24","key":"10.1016\/j.retram.2025.103550_bib0008","first-page":"4642\u20119","article-title":"Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"JCO. 15 d\u00e9c"},{"issue":"Supplement 1","key":"10.1016\/j.retram.2025.103550_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2020-141064","article-title":"Impact of minimal residual disease and chimerism monitoring at different timepoints after allogeneic stem cell transplantation for acute myeloid leukemia","volume":"136","author":"Mart\u00edn-Rojas","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2025.103550_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.patbio.2014.05.011","article-title":"Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC","volume":"62","author":"Guillaume","year":"2014","journal-title":"Pathologie Biologie."},{"issue":"3","key":"10.1016\/j.retram.2025.103550_bib0011","doi-asserted-by":"crossref","first-page":"453\u201174","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2025.103550_bib0012","doi-asserted-by":"crossref","first-page":"838\u201149","DOI":"10.1016\/j.humimm.2021.07.013","article-title":"A practical guide to chimerism analysis: review of the literature and testing practices worldwide","volume":"82","author":"Blouin","year":"2021","journal-title":"Hum. Immunol."},{"issue":"Supplement 1","key":"10.1016\/j.retram.2025.103550_bib0013","first-page":"1792\u20111792","article-title":"Engraftment kinetics and recipient chimerism increase to predict leukemia relapse by ptcy and non-ptcy transplant","volume":"138","author":"Zhang","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103550_bib0014","first-page":"529\u201147","article-title":"Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia","volume":"95","author":"Sterling","year":"2020","journal-title":"Am J Hematol. mai"},{"issue":"5","key":"10.1016\/j.retram.2025.103550_bib0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3324\/haematol.2019.238543","article-title":"Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study","volume":"106","author":"Gambacorta","year":"2020","journal-title":"haematol"},{"issue":"9","key":"10.1016\/j.retram.2025.103550_bib0016","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/genes11090993","article-title":"Short tandem repeats (STRs) as biomarkers for the quantitative follow-up of chimerism after stem cell transplantation: methodological considerations and clinical application","volume":"11","author":"Navarro-Bail\u00f3n","year":"2020","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1016\/j.retram.2025.103550_bib0017","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41375-019-0624-4","article-title":"Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation","volume":"34","author":"Bouvier","year":"2020","journal-title":"Leukemia. mai"},{"issue":"7","key":"10.1016\/j.retram.2025.103550_bib0018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41408-021-00519-y","article-title":"Mixed T cell lineage chimerism in acute leukemia\/MDS using pre-emptive donor lymphocyte infusion strategy\u2014Is it prognostic? \u2014A single-center retrospective study","volume":"11","author":"Sheth","year":"2021","journal-title":"Blood Cancer J. juill"},{"key":"10.1016\/j.retram.2025.103550_bib0019","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41409-022-01615-8","article-title":"Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"57","author":"Lindahl","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.retram.2025.103550_bib0020","first-page":"2339\u201150","article-title":"Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis","volume":"100","author":"Rettig","year":"2021","journal-title":"Ann Hematol. sept"},{"issue":"10","key":"10.1016\/j.retram.2025.103550_bib0021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jtct.2021.06.029","article-title":"Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high-risk acute myelogenous leukemia or myelodysplastic syndrome","volume":"27","author":"Guillaume","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"issue":"24","key":"10.1016\/j.retram.2025.103550_bib0022","first-page":"5675\u201187","article-title":"Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"23","author":"Schmid","year":"2005","journal-title":"JCO. 20 ao\u00fbt"},{"issue":"2","key":"10.1016\/j.retram.2025.103550_bib0023","first-page":"215\u201123","article-title":"Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia","volume":"57","author":"Schmid","year":"2022","journal-title":"Bone Marrow Transplant. f\u00e9vr"},{"issue":"14","key":"10.1016\/j.retram.2025.103550_bib0024","first-page":"3256\u201162","article-title":"Risk stratification\u2013directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Yan","year":"2012","journal-title":"Blood. 5 avr"},{"issue":"11","key":"10.1016\/j.retram.2025.103550_bib0025","doi-asserted-by":"crossref","first-page":"5063\u20114","DOI":"10.1182\/blood-2007-02-072470","article-title":"Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia","volume":"109","author":"Dominietto","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103550_bib0026","first-page":"824\u20116","article-title":"Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning\u2014Eudract #: 2007-002420-15","volume":"57","author":"Hell","year":"2022","journal-title":"Bone Marrow Transplant. mai"},{"issue":"Supplement_1","key":"10.1016\/j.retram.2025.103550_bib0027","doi-asserted-by":"crossref","first-page":"644\u2011644","DOI":"10.1182\/blood-2019-129926","article-title":"Azacitidine for pre-emptive treatment of measurable-residual disease in MDS\/AML patients at high risk of hematological relapse: results of the second cohort of the RELAZA2 trial","volume":"134","author":"Platzbecker","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2025.103550_bib0028","first-page":"385\u201190","article-title":"Tolerability and clinical activity of post-transplantation azacitidine in patients allografted for acute myeloid leukemia treated on the RICAZA trial","volume":"22","author":"Craddock","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation. f\u00e9vr"},{"issue":"26","key":"10.1016\/j.retram.2025.103550_bib0029","doi-asserted-by":"crossref","first-page":"2993\u20113002","DOI":"10.1200\/JCO.19.03345","article-title":"Sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with FLT3 \u2013Internal tandem duplication mutation (SORMAIN)","volume":"38","author":"Burchert","year":"2020","journal-title":"JCO"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:53:12Z","timestamp":1775065992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2452318625000595"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103550","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimerism in blood after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: Results from a cohort study","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103550"}}